Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Clinical trial NCT00644189 · COMPLETED

Trial details

NCT number: NCT00644189
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Marginal Zone Lymphoma Mantle Cell Lymphoma Small Lymphocytic Lymphoma Lymphoplasmacytic Lymphoma Low Grade B-cell Lymphoma, Not Otherwise Specified Diffuse Large B-cell Lymphoma Peripheral T-cell Lymphoma Angioimmunoblastic T-cell Lymphoma Anaplastic Large-cell Lymphoma

Start date: 2008-06-01
Primary completion: 2013-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.